Drug intelligence / Profile preview

methadone + morphine

Development stage
Phase 3
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intrathecal
01

Overview

Methadone + morphine is a combination of two opioid analgesics used for pain management. Both drugs act primarily as full agonists at the µ-opioid receptor, producing potent analgesic effects by altering the perception and response to pain in the central nervous system. Methadone also acts as an antagonist at the N-methyl-D-aspartate (NMDA) receptor and inhibits serotonin and norepinephrine reuptake, which may contribute to its unique antinociceptive properties compared to other opioids. Preclinical studies have shown that combining methadone with morphine results in synergistic analgesia—meaning their combined effect on pain relief is greater than additive—without a corresponding increase in side effects such as gastrointestinal inhibition. This synergy is attributed mainly to activity at different opioid receptor sites, particularly involving the L-isomer of methadone[3][5][8]. The combination may be considered for severe or refractory pain when monotherapy does not provide adequate relief.

02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)σR (Sigma receptors)SIGMAR1 (Sigma non-opioid intracellular receptor 1)

Beyond the preview

Go deeper on methadone + morphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methadone + morphine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call